With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|CD19 Delta Ex2 Isoform as a Target for Alternative Therapies in Relapsed Pediatric B-ALL||Children's Hospital of Philadelphia / Asen Bagashev, PhD||Young Investigator Grants||2016||Pennsylvania|
|Casein Kinase 1 alpha Agonists as Novel Medulloblastoma Inhibitors||University of Miami Miller School of Medicine / David Robbins, PhD||Innovation Grants||2012||Florida|
|Cancer Susceptibility and Signaling Pathways in Low-Grade Brain Tumors||Jewish General Hospital / Bárbara Rivera, PhD||Young Investigator Grants||2017||Quebec|
|Cancer Risk and Incidence in Beckwith-Wiedemann Syndrome||Children's Hospital of Philadelphia / Jennifer Kalish, MD/PhD||Epidemiology Grants||2019||Pennsylvania|
|CAMKV as a Target for Immunotherapy in MYCN-Amplified Neuroblastoma||Children's Hospital of Philadelphia / Robyn Sussman, PhD||Young Investigator Grants||2015||Pennsylvania|
|Ca2+ Release Activated Ca2+ (CRAC) Channels in Control of Leukemic Cell Metabolism and Leukemia Stem Cell Maintenance in T-ALL||New York University School of Medicine / Mate Maus, PhD||Young Investigator Grants||2014||New York|
|Building Capacity for the Clinical Trials Office at Children's Hospital of Wisconsin - Strengthening Phase I & II Trials Infrastructure||Children's Hospital of Wisconsin - Milwaukee / Michael J. Burke, MD||Phase I/II Infrastructure Grants||2015||Wisconsin|
|Building a Texas-based center for neuroblastoma clinical research.||Baylor College of Medicine / Heidi Russell, MD||Phase I/II Infrastructure Grants||2006||Texas|
|Blockade of Mycn in neuroblastoma||University of California San Francisco / William Weiss||Innovation Grants||2008||California|
|Blockade of p53 and Aurora A in Therapy Resistant Neuroblastoma||University of California San Francisco / William Clay Gustafson, MD, PhD||'A' Award Grants||2011||California|